Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01565876
Other study ID # 963-2010-CLIL
Secondary ID
Status Not yet recruiting
Phase N/A
First received July 4, 2011
Last updated March 28, 2012
Start date December 2012
Est. completion date January 2014

Study information

Verified date March 2012
Source Medical Corps, Israel Defense Force
Contact n/a
Is FDA regulated No
Health authority Israel: Israeli Health Ministry Pharmaceutical Administration
Study type Interventional

Clinical Trial Summary

Combat soldiers are required to perform under strenuous physical conditions; hence, their physical fitness is a crucial factor in their survivability.

The Auxiliary Device- "Minkal", is suggested (by its manufactures) to be able to reduce the soldiers' physiological strain by lowering the absolute load being carried by the soldier. As a result, it may improve the soldier's physiological abilities and performance through enduring missions with heavy loads, and may lead to better protection on the soldier from overuse injuries.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 12
Est. completion date January 2014
Est. primary completion date December 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 21 Years to 28 Years
Eligibility Inclusion Criteria:

- Healthy subjects without any of the following: chronic background diseases, cardiovascular, lung or respiratory, heat stroke history, headaches,psychiatric background, musculoskeletal problems, and without drugs use.

- Lack of any acute disease during 2 weeks prior the study.

- Subjects will give their written consent for participating the study after being informed by the study's physician about the study's aims, importance and the possible risks.

Exclusion Criteria:

- Rectal temperature above 39 Celsius degrees.

- HR above maximal HR ( calculated as 220-age)

- The subject's will to stop the test.

- The researcher's/doctor's judgment.

Study Design

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms

  • Physiological Strain of Weight Bearing.

Intervention

Device:
"Minkal"- Auxiliary device to alleviate backload
The participants will undergo 6 days of study. The first day of the study include medical examination, maximal oxigen consumption day and anthropometric mesurments. Then The participants will undergo heat tolerance test 5 times (in different days). first day- without load. second day- with back load of 40% of the body weight. third day- with back load of 40% of the body weight and the Auxilairy Device. fourth day- with back load of 60% of the body weight. fifth day- with back load of 60% of the body weight and the Auxilairy Device. The rectal temperature, skin teperature and heart rate will be mesured each day and compered afterwards.

Locations

Country Name City State
Israel Institute of military physiology Ramat Gan

Sponsors (1)

Lead Sponsor Collaborator
Medical Corps, Israel Defense Force

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physiological Load with and without the auxiliary device The physiological load will be measured using a heat tolerance test(HTT). Each paricipant will undergo a HTT 5 times (in different days). first day- without load. second day- with back load of 40% of the body weight. third day- with back load of 40% of the body weight and the Auxilairy Device. fourth day- with back load of 60% of the body weight. fifth day- with back load of 60% of the body weight and the Auxilairy Device. The rectal temperature, skin teperature and heart rate will be mesured in each HTT and compered afterwards to assess the physiological load. 6 days for each patient. No
Secondary Rectal temperature The Rectal temperature will be mesured by a rectal thermistore during each HTT. 6 days Yes
Secondary Skin temperature The Skin temperature will be mesured by skin thermistores on three sites (chest, leg and arm). 6 days No
Secondary Heart Rate Heart rate will be monitored using a polar watch. 6 days Yes
Secondary Sweat Rate Sweat rate will be calculated from the patient's weight and his water balance. 6 days No